206640 — Boditech Med Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Market Cap
KR₩325bn
Enterprise Value
KR₩271bn
Revenue
KR₩134bn

Annual income statement for Boditech Med, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	72,799	144,131	157,708	118,077	134,219
Cost of Revenue
Gross Profit	41,005	97,651	98,372	70,844	80,918
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	58,262	80,543	105,851	93,409	105,424
Operating Profit	14,537	63,588	51,857	24,668	28,795
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	13,079	60,174	56,039	26,965	31,567
Provision for Income Taxes
Net Income After Taxes	11,897	48,312	47,395	25,281	26,668
Minority Interest
Net Income Before Extraordinary Items
Net Income	11,650	45,489	44,367	24,152	25,947
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	11,650	45,495	44,373	24,152	25,947
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	526	2,055	1,942	1,078	1,171
Dividends per Share